Hoidas John James
CIK: 0001690567
Associated companies
Transaction History
| COSM | ▲ Buy | Grant | 20,000 | $6K | 5/19/2026 | View on chart |
| COSM | ▲ Buy | Grant | 5,000 | $5 | 4/3/2023 | View on chart |
| COSM | ▲ Buy | Grant | 20,000 | $6K | 5/19/2026 | View on chart |
| COSM | ▲ Buy | Grant | 5,000 | $5 | 4/3/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Cosmos Health Subsidiaries Report Record Revenue Milestones
Cosmos Health reported that its CosmoFarm division reached an annualized revenue run rate above $60 million, a 4.3x increase since acquisition. The company stated that robotics and AI systems are expanding capacity to support over $100 million in future revenue. Additionally, its contract manufacturing and Cana Laboratories divisions surpassed $20 million in implied revenue each.
Cosmos Health Subsidiaries Report Record Revenue Milestones. Cosmos Health reported that its CosmoFarm division reached an annualized revenue run rate above $60 million, a 4.3x increase since acquisition. The company stated that robotics and AI systems are expanding capacity to support over $100 million in future revenue. Additionally, its contract manufacturing and Cana Laboratories divisions surpassed $20 million in implied revenue each.